About the Authors
- Kazuko Uno
-
Contributed equally to this work with: Kazuko Uno, Kazuyuki Yoshizaki
Affiliations Department of Organic Fine Chemicals, Division of Biological and Molecular Sciences, The Institute of Scientific and Industrial Research, Osaka University, Suita, Osaka, Japan, Louis Pasteur Center for Medical Research, Kyoto, Kyoto, Japan
- Kazuyuki Yoshizaki
-
Contributed equally to this work with: Kazuko Uno, Kazuyuki Yoshizaki
* E-mail: kyoshi@sanken.osaka-u.ac.jp
Affiliations Department of Organic Fine Chemicals, Division of Biological and Molecular Sciences, The Institute of Scientific and Industrial Research, Osaka University, Suita, Osaka, Japan, Tokushukai Medical Corporation, Tokyo, Japan
- Mitsuhiro Iwahashi
-
Affiliation Higashi Hiroshima Memorial Hospital, Higashi Hiroshima, Hiroshima, Japan
- Jiro Yamana
-
Affiliation Higashi Hiroshima Memorial Hospital, Higashi Hiroshima, Hiroshima, Japan
- Seizo Yamana
-
Affiliation Higashi Hiroshima Memorial Hospital, Higashi Hiroshima, Hiroshima, Japan
- Miki Tanigawa
-
Affiliation Department of Organic Fine Chemicals, Division of Biological and Molecular Sciences, The Institute of Scientific and Industrial Research, Osaka University, Suita, Osaka, Japan
- Katsumi Yagi
-
Affiliation Louis Pasteur Center for Medical Research, Kyoto, Kyoto, Japan
Competing Interests
Kazu Yo has received speaking fees from Chugai Pharmaceutical Co. and is the co-inventor of tocilizumab treatment for Still’s disease. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: KU K. Yoshizaki. Performed the experiments: KU MT. Analyzed the data: KU K. Yagi MI. Contributed reagents/materials/analysis tools: KU. Wrote the paper: KU K. Yoshizaki. Recruited participants and collected data: JY SY MI. Created patients’ database: MT.